FIRST MANHATTAN CO. LLC. - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 246 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
FIRST MANHATTAN CO. LLC. ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$276,939
+74.4%
28,758
+92.7%
0.00%0.0%
Q2 2023$158,802
+1.1%
14,9250.0%0.00%0.0%
Q1 2023$157,011
-15.1%
14,9250.0%0.00%0.0%
Q4 2022$184,920
+20.1%
14,9250.0%0.00%0.0%
Q3 2022$154,000
-10.5%
14,9250.0%0.00%0.0%
Q2 2022$172,000
-8.0%
14,9250.0%0.00%0.0%
Q1 2022$187,000
+7.5%
14,9250.0%0.00%0.0%
Q4 2021$174,000
-10.3%
14,9250.0%0.00%0.0%
Q3 2021$194,000
+1.0%
14,9250.0%0.00%0.0%
Q2 2021$192,000
+15.7%
14,9250.0%0.00%0.0%
Q1 2021$166,000
-1.8%
14,9250.0%0.00%0.0%
Q4 2020$169,000
+26.1%
14,9250.0%0.00%0.0%
Q3 2020$134,000
-13.0%
14,9250.0%0.00%0.0%
Q2 2020$154,000
+2.7%
14,9250.0%0.00%0.0%
Q1 2020$150,000
-18.9%
14,925
+7.2%
0.00%0.0%
Q4 2019$185,000
-14.7%
13,925
-45.1%
0.00%0.0%
Q3 2019$217,000
-45.3%
25,364
-30.2%
0.00%
-50.0%
Q2 2019$397,000
-25.8%
36,364
-8.1%
0.00%
-33.3%
Q1 2019$535,000
+302.3%
39,564
+206.1%
0.00%
+200.0%
Q4 2018$133,00012,9250.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$188,977,00019.02%
13D Management LLC 600,431$6,923,0003.06%
BRIDGER MANAGEMENT, LLC 956,014$11,023,0002.48%
Brown Capital Management 11,641,935$134,232,0001.80%
Price Jennifer C. 520,000$5,996,0001.02%
Monarch Partners Asset Management LLC 272,425$3,141,0000.88%
ALPHASIMPLEX GROUP, LLC 10,510$121,0000.86%
Intrinsic Value Partners, LLC 54,105$624,0000.80%
CLARK ESTATES INC/NY 355,000$4,093,0000.71%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 692$60,000,0000.63%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders